NDC 71390-011

BYFAVO

Remimazolam Besylate

BYFAVO is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Acacia Pharma Ltd. The primary component is Remimazolam Besylate.

Product ID71390-011_4c6a7829-111f-496f-94a9-870568876c2b
NDC71390-011
Product TypeHuman Prescription Drug
Proprietary NameBYFAVO
Generic NameRemimazolam Besylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-07-02
Marketing CategoryNDA / NDA
Application NumberNDA212295
Labeler NameAcacia Pharma Ltd
Substance NameREMIMAZOLAM BESYLATE
Active Ingredient Strength3 mg/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71390-011-11

10 VIAL in 1 CARTON (71390-011-11) > 8 mL in 1 VIAL (71390-011-00)
Marketing Start Date2020-10-06
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [BYFAVO]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BYFAVO
BYFAVO
88817162 not registered Live/Pending
Cosmo Technologies Ltd
2020-03-02
BYFAVO
BYFAVO
88099395 not registered Live/Pending
Cosmo Technologies Ltd
2018-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.